134 related articles for article (PubMed ID: 25368315)
1. Using the RCAS-TVA system to model human cancer in mice.
Ahronian LG; Lewis BC
Cold Spring Harb Protoc; 2014 Nov; 2014(11):1128-35. PubMed ID: 25368315
[TBL] [Abstract][Full Text] [Related]
2. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
[TBL] [Abstract][Full Text] [Related]
3. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
[TBL] [Abstract][Full Text] [Related]
4. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
5. A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.
Seidler B; Schmidt A; Mayr U; Nakhai H; Schmid RM; Schneider G; Saur D
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10137-42. PubMed ID: 18621715
[TBL] [Abstract][Full Text] [Related]
6. Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system.
von Werder A; Seidler B; Schmid RM; Schneider G; Saur D
Nat Protoc; 2012 May; 7(6):1167-83. PubMed ID: 22635109
[TBL] [Abstract][Full Text] [Related]
7. Development of a flexible and specific gene delivery system for production of murine tumor models.
Fisher GH; Orsulic S; Holland E; Hively WP; Li Y; Lewis BC; Williams BO; Varmus HE
Oncogene; 1999 Sep; 18(38):5253-60. PubMed ID: 10498877
[TBL] [Abstract][Full Text] [Related]
8. Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene delivery.
Kabaroff L; Gupta A; Menezes S; Babichev Y; Kandel RC; Swallow CJ; Dickson BC; Gladdy RA
PLoS One; 2014; 9(4):e94817. PubMed ID: 24733554
[TBL] [Abstract][Full Text] [Related]
9. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
10. Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance.
Pao W; Klimstra DS; Fisher GH; Varmus HE
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8764-9. PubMed ID: 12857957
[TBL] [Abstract][Full Text] [Related]
11. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.
Sausville J; Molinolo AA; Cheng X; Frampton J; Takebe N; Gutkind JS; Feldman RA
Clin Cancer Res; 2008 Jun; 14(12):3948-55. PubMed ID: 18559617
[TBL] [Abstract][Full Text] [Related]
12. The receptor for the subgroup C avian sarcoma and leukosis viruses, Tvc, is related to mammalian butyrophilins, members of the immunoglobulin superfamily.
Elleder D; Stepanets V; Melder DC; Senigl F; Geryk J; Pajer P; Plachý J; Hejnar J; Svoboda J; Federspiel MJ
J Virol; 2005 Aug; 79(16):10408-19. PubMed ID: 16051833
[TBL] [Abstract][Full Text] [Related]
13. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein.
Snitkovsky S; Young JA
Virology; 2002 Jan; 292(1):150-5. PubMed ID: 11878917
[TBL] [Abstract][Full Text] [Related]
14. Selective cell targeting and lineage tracing of human induced pluripotent stem cells using recombinant avian retroviruses.
Hildebrand L; Seemann P; Kurtz A; Hecht J; Contzen J; Gossen M; Stachelscheid H
Cell Mol Life Sci; 2015 Dec; 72(23):4671-80. PubMed ID: 26109426
[TBL] [Abstract][Full Text] [Related]
15. An in vivo model to study osteogenic gene regulation: targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter.
Li L; Zhu J; Tu Q; Yamauchi M; Sodek J; Karsenty G; Tang J; Chen J
J Bone Miner Res; 2005 Aug; 20(8):1403-13. PubMed ID: 16007338
[TBL] [Abstract][Full Text] [Related]
16. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
17. An RCAS-TVA-based approach to designer mouse models.
Orsulic S
Mamm Genome; 2002 Oct; 13(10):543-7. PubMed ID: 12420130
[No Abstract] [Full Text] [Related]
18. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
19. The spacing between cysteines two and three of the LDL-A module of Tva is important for subgroup A avian sarcoma and leukosis virus entry.
Rai T; Marble D; Rihani K; Rong L
J Virol; 2004 Jan; 78(2):683-91. PubMed ID: 14694099
[TBL] [Abstract][Full Text] [Related]
20. A novel Flk1-TVA transgenic mouse model for gene delivery to angiogenic vasculature.
Vervoort VS; Lu M; Valencia F; Lesperance J; Breier G; Oshima R; Pasquale EB
Transgenic Res; 2008 Jun; 17(3):403-15. PubMed ID: 18027100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
